rac-N-[1-(1-benzothien-3-yl)ethyl]sulfamide

ID: ALA1088204

PubChem CID: 11637451

Max Phase: Preclinical

Molecular Formula: C10H12N2O2S2

Molecular Weight: 256.35

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(NS(N)(=O)=O)c1csc2ccccc12

Standard InChI:  InChI=1S/C10H12N2O2S2/c1-7(12-16(11,13)14)9-6-15-10-5-3-2-4-8(9)10/h2-7,12H,1H3,(H2,11,13,14)

Standard InChI Key:  HEBFRCMBRXEWNP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
   10.0935  -19.6780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3827  -20.0929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3897  -20.9192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1036  -21.3227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8067  -20.0852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8052  -20.9114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5905  -21.1682    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.0774  -20.5007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5930  -19.8314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8494  -19.0473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6567  -18.8772    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2985  -18.4332    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9131  -18.0931    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   13.7203  -17.9231    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6958  -17.2917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.1125  -17.8750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4  6  1  0
  9 10  1  0
  5  6  2  0
 10 11  1  0
  1  2  2  0
 10 12  1  0
  5  1  1  0
 11 13  1  0
  2  3  1  0
 13 14  1  0
 13 15  2  0
  3  4  2  0
 13 16  2  0
M  END

Alternative Forms

Associated Targets(Human)

CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 256.35Molecular Weight (Monoisotopic): 256.0340AlogP: 1.76#Rotatable Bonds: 3
Polar Surface Area: 72.19Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.96CX Basic pKa: CX LogP: 1.25CX LogD: 1.25
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.88Np Likeness Score: -1.51

References

1. Parker MH, Smith-Swintosky VL, McComsey DF, Huang Y, Brenneman D, Klein B, Malatynska E, White HS, Milewski ME, Herb M, Finley MF, Liu Y, Lubin ML, Qin N, Iannucci R, Leclercq L, Cuyckens F, Reitz AB, Maryanoff BE..  (2009)  Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies.,  52  (23): [PMID:19388676] [10.1021/jm801432r]

Source